Inhibition of T cell activation and autoimmune diabetes using a B cell surface–linked CTLA-4 agonist
J. Clin. Invest. Brian T. Fife, et al. 116:2252
doi:10.1172/JCI27856 [Go to this article.]

Problems with a PDF?